Status:
COMPLETED
Prevalence of ESBL and CPE in French Nursing Homes
Lead Sponsor:
Nantes University Hospital
Conditions:
Enterobacteriaceae Infections
Eligibility:
All Genders
18+ years
Brief Summary
CARBEHPAD is a multicentric randomized prevalence study aiming to assess the frequency of Enterobacteriaceae (ESLB) and carbapenemase producing Enterobacteriaceae (CPE) carriage in Pays de la Loire nu...
Detailed Description
The Pays de la Loire region is impacted by 2 main CPE outbreaks in the 2 major university hospitals in this region. A sample of 50 nursing homes (NH) in Pays de la Loire region (France) will be random...
Eligibility Criteria
Inclusion
- Resident present in the nursing home on the day of the survey.
- Resident having agreed to be included in the study.
- Resident with a social security number.
Exclusion
- \- Resident non-compliant with sampling protocol.
Key Trial Info
Start Date :
October 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2019
Estimated Enrollment :
734 Patients enrolled
Trial Details
Trial ID
NCT03401242
Start Date
October 3 2018
End Date
January 14 2019
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093